Baltimore Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$398K Buy
+3,066
New +$373K 0.64% 44
2018
Q3
$329K Sell
3,066
-300
-9% -$30K 0.53% 54
2018
Q2
$287K Sell
3,366
-67
-2% -$5.5K 0.43% 58
2018
Q1
$266K Hold
3,433
0.4% 60
2017
Q4
$290K Hold
3,433
0.41% 60
2017
Q3
$294K Hold
3,433
0.41% 59
2017
Q2
$283K Hold
3,433
0.41% 58
2017
Q1
$289K Buy
+3,433
New +$275K 0.38% 56

Other funds holding LLY

Baltimore Capital Management's LLY Position: Q1 2019 in Review

Baltimore Capital Management opened a new position in Eli Lilly (LLY) in Q1 2019: 3,066 shares worth $398K. The stake represents 0.64% of the portfolio and ranks #44 among its holdings. This is a return to the name: Baltimore Capital Management previously reported a position in LLY as recently as Q3 2018.

Baltimore Capital Management first reported a position in LLY in Q1 2017 and has held it in 8 quarters since. 1,604 funds tracked by Wall St. Rank hold LLY as of Q1 2019.

  • Baltimore Capital Management held 3,066 shares of Eli Lilly worth $398K as of Q1 2019.
  • Eli Lilly was a new Baltimore Capital Management position in Q1 2019.
  • Eli Lilly made up 0.64% of Baltimore Capital Management's portfolio in Q1 2019, its #44 holding.
  • Baltimore Capital Management first reported a position in Eli Lilly in Q1 2017 and has held it in 8 quarters since.
  • 1,604 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2019.

Based on Baltimore Capital Management's 13F filing for Q1 2019, filed 14 May 2019.